quality compounders

While markets chase the AI hype, medtech quietly trades at decade-lows. Here’s why that’s an opportunity for long-term patient investors.

With a 20-year CAGR of 14.1%, Thermo Fisher has repeatedly shown how temporary headwinds create long-term value for patient shareholders.

Why Eurofins Scientific is currently among the largest positions in our Global Equity Fund

The most important company you've never heard of. Why We Like Verisign (NASDAQ:VRSN)

Investors can do a lot worse than picking quality growth stocks and staying the course. View from a personal experience

For Ninety One, quality means a long-term sustainable competitive advantage, sourced from innovation.

One of the ASX's true market champions has beat analyst guidance and the market's lofty expectations. Again.